Note: This press release contains "forward-looking statements" within the meaning of the federal securities laws. These forward-looking statements include, without limitation, VaxGen's and Raven's ability to meet the conditions necessary to close the proposed merger between the two companies, the benefits of the proposed merger, the ability to meet the stated drug development and financial objectives of the merged company, and the ability to and timing to successfully integrate Raven and VaxGen following consummation of the merger. These statements are subject to risks and uncertainties that could cause actual results and events to differ materially from those anticipated. Additional information concerning these and other risk factors is contained in VaxGen's Annual Report on Form 10-K for the year ended December 31, 2006 and most recently filed Quarterly Report on Form 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date of this release. VaxGen and Raven undertake no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date of this release except as required by law.
Additional Information and Where to Find It
VaxGen has filed a registration statement on Form
|SOURCE VaxGen Inc.|
Copyright©2008 PR Newswire.
All rights reserved